Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 18401-18450 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT02983461
Use of Sildenafil for Treatment of Urinary Incontinence
PHASE1
Active, not recruiting
24 participants
Started: Mar 10, 2017 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT02989636
Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma
PHASE1
Active, not recruiting
21 participants
Started: Mar 10, 2017 · Completed: Nov 30, 2026
1 condition
4 sponsors
2 locations
NCT03080948
Risk Stratification Among Individuals Who Have Many Moles on Their Skin
N/A
Active, not recruiting
73 participants
Started: Mar 9, 2017 · Completed: Mar 31, 2026
1 condition
4 sponsors
4 locations
NCT03054896
A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome
PHASE2
Active, not recruiting
69 participants
Started: Mar 8, 2017 · Completed: Dec 1, 2027
1 condition
2 sponsors
3 locations
NCT03011814
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
PHASE1/PHASE2
Active, not recruiting
38 participants
Started: Mar 8, 2017 · Completed: Aug 30, 2026
8 conditions
2 sponsors
4 locations
NCT03089203
CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer
PHASE1
Active, not recruiting
23 participants
Started: Mar 8, 2017 · Completed: Dec 8, 2038
1 condition
1 sponsor
1 location
NCT03220373
Predicting Dropout and Outcome From Neuropsychological Functions in SUD Patients
N/A
Active, not recruiting
200 participants
Started: Mar 7, 2017 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT02978118
Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)
N/A
Active, not recruiting
67 participants
Started: Mar 7, 2017 · Completed: Oct 31, 2028
2 conditions
2 sponsors
1 location
NCT02998268
Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
PHASE2
Active, not recruiting
42 participants
Started: Mar 7, 2017 · Completed: Sep 30, 2026
1 condition
2 sponsors
4 locations
NCT03023540
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
PHASE3
Active, not recruiting
187 participants
Started: Mar 7, 2017 · Completed: Dec 31, 2024
1 condition
7 sponsors
23 locations
NCT02812420
Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery
EARLY_PHASE1
Active, not recruiting
54 participants
Started: Mar 7, 2017 · Completed: Dec 31, 2027
19 conditions
2 sponsors
1 location
NCT03012399
Hypnosedation in Relaxing Patients Undergoing Breast Cancer Surgery
NA
Active, not recruiting
50 participants
Started: Mar 7, 2017 · Completed: Apr 30, 2027
8 conditions
2 sponsors
1 location
NCT02886065
A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM
PHASE1
Active, not recruiting
19 participants
Started: Mar 7, 2017 · Completed: Sep 15, 2026
1 condition
3 sponsors
6 locations
NCT03036488
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)
PHASE3
Active, not recruiting
1,174 participants
Started: Mar 7, 2017 · Completed: Oct 14, 2025
1 condition
1 sponsor
193 locations
NCT02960087
Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
NA
Active, not recruiting
334 participants
Started: Mar 6, 2017 · Completed: Oct 30, 2029
1 condition
1 sponsor
7 locations
NCT03009981
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
PHASE3
Active, not recruiting
504 participants
Started: Mar 6, 2017 · Completed: Jan 1, 2026
1 condition
2 sponsors
69 locations
NCT06715917
Multicentre GMK UNI Anatomical Cementless Study - FR
N/A
Active, not recruiting
249 participants
Started: Mar 6, 2017 · Completed: Mar 6, 2032
3 conditions
1 sponsor
5 locations
NCT02864004
Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)
PHASE3
Active, not recruiting
134 participants
Started: Mar 3, 2017 · Completed: Jan 30, 2025
1 condition
1 sponsor
20 locations
NCT03074513
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
PHASE2
Active, not recruiting
133 participants
Started: Mar 3, 2017 · Completed: Sep 30, 2027
21 conditions
2 sponsors
1 location
NCT03020030
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
PHASE3
Active, not recruiting
560 participants
Started: Mar 3, 2017 · Completed: Nov 30, 2034
1 condition
2 sponsors
9 locations
NCT03069378
A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
PHASE2
Active, not recruiting
41 participants
Started: Mar 3, 2017 · Completed: Mar 31, 2026
3 conditions
3 sponsors
5 locations
NCT02983578
Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer
PHASE2
Active, not recruiting
39 participants
Started: Mar 2, 2017 · Completed: Aug 30, 2025
25 conditions
3 sponsors
1 location
NCT03363711
AYA STEPS RCT: AYA Self-Management Via Texting, Education & Plans for Survivors
N/A
Active, not recruiting
25 participants
Started: Mar 1, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03057964
PDL and Fractional Photothermolysis for Postsurgical Scars
NA
Active, not recruiting
76 participants
Started: Mar 1, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03230435
Health Related Quality of Life for Patients With Anorexia Nervosa in Denmark.
N/A
Active, not recruiting
496 participants
Started: Mar 1, 2017 · Completed: Jan 1, 2025
2 conditions
3 sponsors
1 location
NCT02865408
Amino Acid Nutrition in the Critically-ill
NA
Active, not recruiting
30 participants
Started: Mar 1, 2017 · Completed: Feb 28, 2026
3 conditions
1 sponsor
1 location
NCT04987060
Intrastromal Fresh Human Corneal Lenticule Implantation Using Smile Surgery for Treatment of Irregular Corneal Astigmatism After Penetrating Keratoplasty (new Approach)
NA
Active, not recruiting
24 participants
Started: Mar 1, 2017 · Completed: Dec 1, 2027
1 condition
1 sponsor
1 location
NCT04695899
Zirconia Implants for Replacement of a Single Tooth
N/A
Active, not recruiting
14 participants
Started: Mar 1, 2017 · Completed: Feb 28, 2030
1 condition
1 sponsor
1 location
NCT03087136
A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil
N/A
Active, not recruiting
100 participants
Started: Mar 1, 2017 · Completed: Mar 31, 2025
1 condition
2 sponsors
8 locations
NCT04723836
Optimal Nutrition for Prevention of Hypertension in Pregnancy
NA
Active, not recruiting
2,250 participants
Started: Mar 1, 2017 · Completed: Dec 31, 2025
2 conditions
3 sponsors
3 locations
NCT03047135
Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis
PHASE2
Active, not recruiting
51 participants
Started: Mar 1, 2017 · Completed: May 1, 2026
1 condition
2 sponsors
4 locations
NCT03066843
Photodynamic Therapy Incubation Times for Actinic Keratosis
NA
Active, not recruiting
60 participants
Started: Mar 1, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03063372
Pomegranate Supplementation and Well-Being Among Medical Students and Residents
NA
Active, not recruiting
50 participants
Started: Feb 28, 2017 · Completed: Feb 1, 2027
3 conditions
2 sponsors
1 location
NCT03308929
Prospective G7 Dual Mobility Total Hip PMCF
N/A
Active, not recruiting
250 participants
Started: Feb 28, 2017 · Completed: Feb 28, 2029
5 conditions
1 sponsor
6 locations
NCT03069326
A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis
PHASE2
Active, not recruiting
30 participants
Started: Feb 27, 2017 · Completed: Feb 28, 2026
1 condition
4 sponsors
7 locations
NCT02820506
Sentinel Node Mapping in Women With Endometrial and Cervical Cancer
NA
Active, not recruiting
300 participants
Started: Feb 27, 2017 · Completed: Jan 31, 2026
2 conditions
3 sponsors
4 locations
NCT03070327
BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma
PHASE1
Active, not recruiting
20 participants
Started: Feb 27, 2017 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT03046862
Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer
PHASE2
Active, not recruiting
31 participants
Started: Feb 25, 2017 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT03060720
Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
N/A
Active, not recruiting
271 participants
Started: Feb 24, 2017 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT06581822
Biomarkers for Pharmacoresponse in Bipolar Disorder - Coagulation
N/A
Active, not recruiting
68 participants
Started: Feb 24, 2017 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT03091660
S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer
PHASE3
Active, not recruiting
1,000 participants
Started: Feb 24, 2017 · Completed: Jun 15, 2026
3 conditions
2 sponsors
174 locations
NCT02977715
JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo
PHASE3
Active, not recruiting
1,600 participants
Started: Feb 23, 2017 · Completed: Dec 31, 2025
1 condition
4 sponsors
1 location
NCT02914535
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
PHASE3
Active, not recruiting
1,173 participants
Started: Feb 23, 2017 · Completed: Sep 30, 2026
1 condition
2 sponsors
323 locations
NCT02999477
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
PHASE1
Active, not recruiting
32 participants
Started: Feb 23, 2017 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT02912312
Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer
PHASE2
Active, not recruiting
805 participants
Started: Feb 23, 2017 · Completed: Feb 28, 2031
9 conditions
2 sponsors
12 locations
NCT02834637
A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls
PHASE3
Active, not recruiting
930 participants
Started: Feb 23, 2017 · Completed: Mar 31, 2027
1 condition
8 sponsors
1 location
NCT02926911
Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS
NA
Active, not recruiting
997 participants
Started: Feb 22, 2017 · Completed: Jul 31, 2028
2 conditions
9 sponsors
141 locations
NCT02988960
A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
PHASE1
Active, not recruiting
163 participants
Started: Feb 22, 2017 · Completed: Mar 31, 2026
1 condition
1 sponsor
22 locations
NCT02757274
Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence
N/A
Active, not recruiting
1,054 participants
Started: Feb 22, 2017 · Completed: Jul 31, 2027
1 condition
2 sponsors
28 locations
NCT03083288
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer
PHASE1
Active, not recruiting
30 participants
Started: Feb 22, 2017 · Completed: Feb 22, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
366
367
368
369
370
371
372
More pages
431
Next